CLINICAL TRIALS PROFILE FOR EMBEDA
✉ Email this page to a colleague
All Clinical Trials for Embeda
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00415597 ↗ | Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain | Completed | Pfizer | Phase 3 | 2006-12-01 | Open-Label, Safety Study to evaluate the long-term safety of Kadian NT (ALO-01) administered for up to 12 months. |
NCT00420992 ↗ | A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee | Completed | Pfizer | Phase 3 | 2006-12-01 | The purpose of this study is to evaluate the efficacy of Kadian NT (ALO-01) compared with placebo for treating moderate to severe chronic pain over a 12 week period. |
NCT01100437 ↗ | Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients | Terminated | Pfizer | Phase 4 | 2010-04-01 | This study will evaluate whether crushed EMBEDA capsules induce clinical opiate withdrawal signs and symptoms in opioid-dependent patients with chronic non-cancer pain who are stabilized on EMBEDA. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Embeda
Condition Name
Clinical Trial Locations for Embeda
Trials by Country
Clinical Trial Progress for Embeda
Clinical Trial Phase
Clinical Trial Sponsors for Embeda
Sponsor Name